Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003

Cancer Res. 2003 Dec 1;63(23):8558-9; author reply 8560.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dideoxynucleosides*
  • Drug Monitoring / methods
  • Humans
  • Neoplasms / diagnostic imaging*
  • Neoplasms / drug therapy
  • Radiopharmaceuticals*
  • Tomography, Emission-Computed / methods

Substances

  • Dideoxynucleosides
  • Radiopharmaceuticals
  • alovudine